The compound of Formula 1 is a novel piperazinylalkylpyrazole derivative, which particulary has T-type Ca2+ channel blocking effect and thus can be useful as a therapeutic agent for nerve and muscle pain."/>
公开/公告号US7544686B2
专利类型
公开/公告日2009-06-09
原文格式PDF
申请/专利号US20060509769
申请日2006-08-25
分类号A61K31/415;A61K31/4155;A61K31/496;C07D207/335;C07D401/10;C07D405/04;
国家 US
入库时间 2022-08-21 19:29:14